IP29: Benign Prostatic Hyperplasia: Surgical Therapy & New Technology IV

IP29: Benign Prostatic Hyperplasia: Surgical Therapy & New Technology IV

Saturday, May 16, 2026 7:00 AM to 9:00 AM · 2 hr. (America/New_York)
147A
Poster and Podium Sessions
BPHNew Technologies/Instruments/Devices

Saturday, May 16

IP29-01: Quantitative Evaluation of Continuous Bladder Irrigation Through Automated Monitoring

Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
Abbas Hammoud

IP29-02: Durability and long-term outcomes of the prostatic urethral lift (UroLift): a multi-surgeon retrospective analysis of 1990 cases

Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
Daniel Baetzhold

IP29-03: Evolution of Surgical Management for Benign Prostatic Obstruction: A Decade of Real-World Data Revealing the Shift from TURP to Laser Enucleation

Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
Leo Federico Stadelmeier

IP29-04: COMPARISON OF PERIOPERATIVE OUTCOMES BETWEEN HOLMIUM LASER ENUCLEATION OF THE PROSTATE AND ROBOT ASSISTED SIMPLE PROSTATECTOMY FOR BENIGN PROSTATIC HYPERPLASIA

Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
Rishabh Simhal · Ochsner Medical Center

IP29-05: Interim Analysis of a Multicenter Randomized Trial on Patient-Initiated Preoperative Pelvic Floor Physical Therapy to Reduce Transient Stress Urinary Incontinence Following Holmium Laser Enucleation of the Prostate

Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
Narmina Khanmammadova · Department of Urology, University of California, Irvine

IP29-06: Randomized Control Trial of BPH TURBO procedure using the OptilumeBPH system with 3 Block Techniques – First World Reporting of Out-Patient In-Office Experience Under Local Anesthesia

Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
Adel Arezki · McGill University

IP29-07: Symptom-Free Rate After Prostatic Artery Embolization and Impact of Cardiovascular Risk Factors

Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
Khaled Alghueiri · Giessen University Hospital , Germany

IP29-08: Impact of Ice Chilled Saline Catheter Balloon and Bladder Irrigation on Perioperative Hemostasis, Pain, and Recovery Following Aquablation Therapy for BPH: A Novel Contemporary Comparative Series

Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
Adel Arezki · McGill University

IP29-09: Identifying Predictors of Retreatment and the Optimal Prostate Size Following Convective Water Vapor Thermal Therapy

Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
Milad Bonakdar Hashemi · Mayo Clinic

IP29-10: Learning Curve of Aquablation: Insights from the First 252 Consecutive Cases in a High-Volume European Centre

Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
Tiago Rodrigues · Hospital Cruz Vermelha

IP29-11: Same-Day Discharge after HoLEP: A Community Experience from our first 100 cases at a Rural Small Ambulatory Surgical Center.

Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
Victor Sandoval · University of Rochester

IP29-12: Less Is More: Smaller Sheath Size Reduces Complications Without Compromising Efficiency in Laser Enucleation of the Prostate

Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
Zachary Brilliant

IP29-13: The prostate elasticity cause lower urinary tract symptoms and dysfunctions independently

Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
Yu Endo · Fukushima Medical University

IP29-14: The Impact of Convective Water Vapor Thermal Therapy (Rezum) on Male Sexual Function: A Systematic Review and Meta-Analysis

Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
Ibrahim khalil · Hamad Medical Corporation

IP29-15: Confidence vs Competency: A Multicenter Evaluation of Surgical Skill Attainment in Laser Enucleation of the Prostate Training, A Prostate Enucleation Collaborative Initiative

Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
Carl Ceraolo · University of Rochester

IP29-16: HoLEP and Its Miniaturized Variants Provide Superior Perioperative and Postoperative Outcomes Compared to TURP: A Systematic Review and Meta-analysis

Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
Braulio Manzo Perez · Hospital Angeles & HRAEB Leon

IP29-17: National multicenter prospective study on blue laser vaporization of the prostate for benign prostatic hyperplasia using the ejaculation preservation method (with 3-month follow-up results)

Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
Zhihui Zou · The First Affiliated Hospital of Anhui Medical University

IP29-18: Ejaculation-Sparing Techniques in Bladder Outlet Obstruction Procedures: A Systematic Review and Meta-analysis

Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
David Hinojosa Gonzalez · Massachusetts General Hospital

IP29-19: Histoblast: Preliminary Medium-Term Outcomes of a Modified HIFU Technique for Benign Prostatic Hyperplasia Treatment – A Case Series

Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
Carlos Garcia Becerra · Urovallarta medical center

IP29-20: Variation in Discussion of Recovery and Treatment Durability Across Surgical Options for BPH

Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
Maria Mogollon

IP29-21: Reproducibility of Aquablation Outcomes Across Surgeon Experience Levels: A Pooled Multicenter Comparative Analysis

Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
Dean Elterman · University of Toronto

IP29-22: Prior Prostate Surgery is an Independent Risk Factor for Urinary Incontinence, Weak Stream and Bothersome Urinary Symptoms in the Early Postoperative Period after Holmium Laser Enucleation of Prostate.

Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
Maithili Gopalakrishnan · SUNY Upstate Medical University

IP29-23: Temporal and Geographic Trends in Surgical Management of Benign Prostatic Hyperplasia in the US Veteran Population

Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
Michael Tram

IP29-24: Retrospective analysis of minimally invasive laser enucleation of the prostate (MiLEP) using a thulium fiber laser with slim and ultra-slim resectoscopes

Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
Alim Dymov · Sechenov University

IP29-25: Incidental Prostate Cancer Following HoLEP: Institutional Outcomes and Early Experience With PSA-Based Surveillance With Minimum 2 Years of Follow-Up

Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
Raviraj Rege · University of Rochester School of Medicine and Dentistry

IP29-26: Safety and Feasibility of Holmium Laser Enucleation of the Prostate in Octogenarians and Nonagenarians with Large Glands: A Multicenter Study

Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
Narmina Khanmammadova · Department of Urology, University of California, Irvine

IP29-27: Patient Satisfaction after 12 Months using the Zenflow Spring System for treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia

Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
Brian Mazzarella · Urology Austin

IP29-28: Incorporation of Real-time Quantitative Force Feedback within a Hydrogel HoLEP Benchtop Simulator

Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
Bennett Ye

IP29-29: Multi-Institutional Learning Curve of Single Port Transvesical Robotic Simple Prostatectomy from the Single Port Advanced Research Consortium (SPARC)

Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
Rui Miguel Marques Bernardino · Cleveland Clinic

IP29-30: Water Vapor Therapy (Rezum) in the Management of Benign Prostatic Hyperplasia: Still Room for Improvement (Technique Modification)

Saturday, May 16, 2026 7:00 AM to 9:00 AM
147A
Hamad Alakrash · Prince Sultan Military Medical City

Log in

See all the content and easy-to-use features by logging in or registering!